Endoscopic Resection for Gastric Adenocarcinoma of the Fundic Gland Type: A Case Series.
Hwa Jin LeeGwang Ha KimDong Chan JooMoon Won LeeBong Eun LeeKyungbin KimPublished in: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2023)
The fundic gland type (GA-FG) of gastric adenocarcinoma is a rare variant of gastric cancer recently included in the 5th edition of the World Health Organization's classification of digestive system tumors. Five patients with GA-FG underwent an endoscopic resection at our institution. None of the patients had a Helicobacter pylori infection. Four lesions were located in the upper third of the stomach, and one was in the lower third. Three lesions had a IIa shape, while two resembled a subepithelial tumor. An endoscopic submucosal dissection was performed in four patients and endoscopic mucosal resection in one. Tumor cells were composed of well-differentiated columnar cells mimicking fundic gland cells, and the median tumor size was 10 mm. Three lesions exhibited submucosal invasion. No lymphatic or venous invasion was observed. Tumor cells were positive for MUC6 in all five cases; one case was focally positive for MUC5AC. No recurrence was observed during a median follow-up period of 13 months. An endoscopic resection can be a safe treatment modality for GA-FG, considering its small size and low risk of recurrence or metastasis.
Keyphrases
- end stage renal disease
- endoscopic submucosal dissection
- pet ct
- helicobacter pylori infection
- ultrasound guided
- ejection fraction
- induced apoptosis
- newly diagnosed
- chronic kidney disease
- squamous cell carcinoma
- prognostic factors
- cell cycle arrest
- machine learning
- deep learning
- patient reported outcomes
- locally advanced
- ulcerative colitis
- replacement therapy